A detailed history of Susquehanna International Group, LLP transactions in Bio N Tech Se stock. As of the latest transaction made, Susquehanna International Group, LLP holds 105,009 shares of BNTX stock, worth $10.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,009
Previous 6,363 1550.31%
Holding current value
$10.5 Million
Previous $511,000 2340.51%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.36 - $124.66 $7.73 Million - $12.3 Million
98,646 Added 1550.31%
105,009 $12.5 Million
Q2 2024

Aug 15, 2024

SELL
$80.36 - $102.87 $7.38 Million - $9.45 Million
-91,843 Reduced 93.52%
6,363 $511,000
Q1 2024

May 07, 2024

BUY
$88.96 - $112.35 $8.74 Million - $11 Million
98,206 New
98,206 $9.06 Million
Q3 2023

Nov 14, 2023

BUY
$98.5 - $125.08 $1.58 Million - $2.01 Million
16,069 Added 13.53%
134,807 $14.6 Million
Q2 2023

Aug 11, 2023

BUY
$102.58 - $129.66 $6 Million - $7.58 Million
58,483 Added 97.06%
118,738 $12.8 Million
Q1 2023

May 16, 2023

SELL
$122.57 - $153.67 $4.31 Million - $5.4 Million
-35,159 Reduced 36.85%
60,255 $7.51 Million
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $896,041 - $1.41 Million
7,566 Added 8.61%
95,414 $14.3 Million
Q3 2022

Nov 14, 2022

SELL
$127.65 - $183.11 $39.5 Million - $56.7 Million
-309,657 Reduced 77.9%
87,848 $11.8 Million
Q2 2022

Aug 15, 2022

SELL
$123.25 - $186.24 $7.65 Million - $11.6 Million
-62,063 Reduced 13.5%
397,505 $59.3 Million
Q1 2022

May 16, 2022

SELL
$126.25 - $231.85 $8.61 Million - $15.8 Million
-68,215 Reduced 12.92%
459,568 $78.4 Million
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $86.6 Million - $145 Million
-399,558 Reduced 43.09%
527,783 $136 Million
Q3 2021

Nov 15, 2021

BUY
$205.93 - $447.23 $48.6 Million - $106 Million
236,170 Added 34.17%
927,341 $253 Million
Q2 2021

Aug 11, 2021

BUY
$113.32 - $241.49 $30.1 Million - $64.2 Million
265,700 Added 62.45%
691,171 $155 Million
Q1 2021

May 17, 2021

SELL
$85.73 - $119.5 $16.7 Million - $23.3 Million
-195,273 Reduced 31.46%
425,471 $46.5 Million
Q4 2020

Feb 16, 2021

BUY
$72.71 - $129.54 $11.1 Million - $19.7 Million
151,992 Added 32.42%
620,744 $50.6 Million
Q3 2020

Nov 16, 2020

BUY
$57.81 - $104.17 $19 Million - $34.2 Million
328,684 Added 234.66%
468,752 $32.5 Million
Q2 2020

Aug 14, 2020

BUY
$38.58 - $66.74 $5.4 Million - $9.35 Million
140,068 New
140,068 $9.35 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.